Simultaneous very late stent thrombosis in multiple coronary arteries

Seshasayee Narasimhan, Nassim Rostane Krim, Gary Silverman, E. Scott Monrad

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We report 2 noteworthy cases of very late stent thrombosis presenting as ST-segmentelevation myocardial infarction, with vastly different manifestations. Both patients were women who had histories of multivessel percutaneous coronary intervention with firstgeneration sirolimus-eluting stents, in 2005 and 2006. On the more recent occasions reported here, one underwent successful multivessel primary percutaneous coronary intervention, while the other underwent successful multivessel "plain old balloon angioplasty." Both were discharged from the hospital with advice to stop smoking and to follow a lifelong regimen of aspirin and clopidogrel. On the basis of these two cases and our review of the current literature, we ask whether it is now prudent to recommend lifelong dual antiplatelet therapy after drug-eluting stent deployment. Moreover, in order to account for cases of stent thrombosis that occur ≥5 years after drug-eluting stent implantation, should we perhaps suggest the addition of "extremely late stent thrombosis" to the existing Academic Research Consortium classification?.

Original languageEnglish (US)
Pages (from-to)630-634
Number of pages5
JournalTexas Heart Institute Journal
Volume39
Issue number5
StatePublished - Oct 2012

Fingerprint

Stents
Coronary Vessels
Thrombosis
Drug-Eluting Stents
clopidogrel
Percutaneous Coronary Intervention
Balloon Angioplasty
Sirolimus
Aspirin
Smoking
Myocardial Infarction
Research
Therapeutics

Keywords

  • Aspirin
  • Clopidogrel
  • Coronary restenosis/etiology
  • Coronary thrombosis/etiology
  • Drug delivery systems/adverse effects
  • Immunosuppressive agents
  • Paclitaxel
  • Platelet aggregation inhibitors/therapeutic use
  • Sirolimus/therapeutic use
  • Stent thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Simultaneous very late stent thrombosis in multiple coronary arteries. / Narasimhan, Seshasayee; Krim, Nassim Rostane; Silverman, Gary; Monrad, E. Scott.

In: Texas Heart Institute Journal, Vol. 39, No. 5, 10.2012, p. 630-634.

Research output: Contribution to journalArticle

Narasimhan, S, Krim, NR, Silverman, G & Monrad, ES 2012, 'Simultaneous very late stent thrombosis in multiple coronary arteries', Texas Heart Institute Journal, vol. 39, no. 5, pp. 630-634.
Narasimhan, Seshasayee ; Krim, Nassim Rostane ; Silverman, Gary ; Monrad, E. Scott. / Simultaneous very late stent thrombosis in multiple coronary arteries. In: Texas Heart Institute Journal. 2012 ; Vol. 39, No. 5. pp. 630-634.
@article{1c6ba23a6adb4add8939324835dca3cd,
title = "Simultaneous very late stent thrombosis in multiple coronary arteries",
abstract = "We report 2 noteworthy cases of very late stent thrombosis presenting as ST-segmentelevation myocardial infarction, with vastly different manifestations. Both patients were women who had histories of multivessel percutaneous coronary intervention with firstgeneration sirolimus-eluting stents, in 2005 and 2006. On the more recent occasions reported here, one underwent successful multivessel primary percutaneous coronary intervention, while the other underwent successful multivessel {"}plain old balloon angioplasty.{"} Both were discharged from the hospital with advice to stop smoking and to follow a lifelong regimen of aspirin and clopidogrel. On the basis of these two cases and our review of the current literature, we ask whether it is now prudent to recommend lifelong dual antiplatelet therapy after drug-eluting stent deployment. Moreover, in order to account for cases of stent thrombosis that occur ≥5 years after drug-eluting stent implantation, should we perhaps suggest the addition of {"}extremely late stent thrombosis{"} to the existing Academic Research Consortium classification?.",
keywords = "Aspirin, Clopidogrel, Coronary restenosis/etiology, Coronary thrombosis/etiology, Drug delivery systems/adverse effects, Immunosuppressive agents, Paclitaxel, Platelet aggregation inhibitors/therapeutic use, Sirolimus/therapeutic use, Stent thrombosis",
author = "Seshasayee Narasimhan and Krim, {Nassim Rostane} and Gary Silverman and Monrad, {E. Scott}",
year = "2012",
month = "10",
language = "English (US)",
volume = "39",
pages = "630--634",
journal = "Texas Heart Institute Journal",
issn = "0730-2347",
publisher = "Texas Heart Institute",
number = "5",

}

TY - JOUR

T1 - Simultaneous very late stent thrombosis in multiple coronary arteries

AU - Narasimhan, Seshasayee

AU - Krim, Nassim Rostane

AU - Silverman, Gary

AU - Monrad, E. Scott

PY - 2012/10

Y1 - 2012/10

N2 - We report 2 noteworthy cases of very late stent thrombosis presenting as ST-segmentelevation myocardial infarction, with vastly different manifestations. Both patients were women who had histories of multivessel percutaneous coronary intervention with firstgeneration sirolimus-eluting stents, in 2005 and 2006. On the more recent occasions reported here, one underwent successful multivessel primary percutaneous coronary intervention, while the other underwent successful multivessel "plain old balloon angioplasty." Both were discharged from the hospital with advice to stop smoking and to follow a lifelong regimen of aspirin and clopidogrel. On the basis of these two cases and our review of the current literature, we ask whether it is now prudent to recommend lifelong dual antiplatelet therapy after drug-eluting stent deployment. Moreover, in order to account for cases of stent thrombosis that occur ≥5 years after drug-eluting stent implantation, should we perhaps suggest the addition of "extremely late stent thrombosis" to the existing Academic Research Consortium classification?.

AB - We report 2 noteworthy cases of very late stent thrombosis presenting as ST-segmentelevation myocardial infarction, with vastly different manifestations. Both patients were women who had histories of multivessel percutaneous coronary intervention with firstgeneration sirolimus-eluting stents, in 2005 and 2006. On the more recent occasions reported here, one underwent successful multivessel primary percutaneous coronary intervention, while the other underwent successful multivessel "plain old balloon angioplasty." Both were discharged from the hospital with advice to stop smoking and to follow a lifelong regimen of aspirin and clopidogrel. On the basis of these two cases and our review of the current literature, we ask whether it is now prudent to recommend lifelong dual antiplatelet therapy after drug-eluting stent deployment. Moreover, in order to account for cases of stent thrombosis that occur ≥5 years after drug-eluting stent implantation, should we perhaps suggest the addition of "extremely late stent thrombosis" to the existing Academic Research Consortium classification?.

KW - Aspirin

KW - Clopidogrel

KW - Coronary restenosis/etiology

KW - Coronary thrombosis/etiology

KW - Drug delivery systems/adverse effects

KW - Immunosuppressive agents

KW - Paclitaxel

KW - Platelet aggregation inhibitors/therapeutic use

KW - Sirolimus/therapeutic use

KW - Stent thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84870170606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870170606&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 630

EP - 634

JO - Texas Heart Institute Journal

JF - Texas Heart Institute Journal

SN - 0730-2347

IS - 5

ER -